Short Name | Pegaptanib sodium |
Description | Pegaptanib sodium is an RNA aptamer directed against vascular endothelial growth factor (VEGF)-165. Pegaptanib could be used for the study of neovascular age-related macular degeneration (AMD). |
Technology Applications | Metabolic Disease; Inflammation/Immunology |
Structure | |
Appearance | White to off-white |
Storage | -20°C, sealed storage, away from moisture |
Synonym | EYE001; NX1838 |
Formula Weight | 50000 |
CAS No. | 222716-86-1 |
Affinity & Target | VEGFR |
Catalog: CDAPT24-001-L
Catalog: CDAPT24-002-L
Catalog: CDAPT24-003-L
Catalog: CDAPT24-004-L
Catalog: CDAPT24-005-L
Catalog: CDAPT24-006-L
Catalog: CDAPT24-007-L
Catalog: CDAPT24-008-L